Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
Titel:
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
Auteur:
Wang, Yujue Liu, Sixue Yang, Zhentao Algazi, Alain P. Lomeli, Shirley H. Wang, Yan Othus, Megan Hong, Aayoung Wang, Xiaoyan Randolph, Chris E. Jones, Alexis M. Bosenberg, Marcus W. Byrum, Stephanie D. Tackett, Alan J. Lopez, Henry Yates, Clayton Solit, David B. Ribas, Antoni Piva, Marco Moriceau, Gatien Lo, Roger S.